NEUREN PHARMACEUTICALS LIMITED earnings per share and revenue

NEU earnings per share for the last semiannual are 0.86 AUD whereas the estimation was 0.98 AUD which accounts for -12.46% surprise. Företagets omsättning för samma period uppgår till 175.70 M AUD trots den uppskattade siffran 165.29 M AUD. Estimated earnings per share for the next semiannual are 0.16 AUD, and revenue is expected to reach 33.85 M AUD. Also watch annual changes over time to get a bigger picture of NEU earnings per share and revenue dynamics.